About ABBV-744 as a potential therapeutic option for aggressive cancers
In combination with These clinical trials described previously mentioned, there have also been pre-clinical studies that showed excellent effectiveness in terms of both safety and effectiveness versus AML.
Celastrol was recognized being a Myb inhibitor that suppressed C/EBPβ action and repre